Peiman Hematti

17PUBLICATIONS
131CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 24, 2026
Biocompatible Glycoconjugation Enables Sensitive In Vivo Cell Tracking by PET/CT.

|May 22, 2026
Oncometabolite signatures from tumor-stroma crosstalk as potential non-invasive biomarkers.

|Aug 14, 2025
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma.

Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy

|Jul 24, 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.

Nausheen Ahmed, Swetha Kambhampati Thiruvengadam, Mehdi Hamadani

|Jul 02, 2025
Radiation therapy results in preferential tumor antigen-specific lymphodepletion in head and neck cancer.

Joseph Zenga, Musaddiq J Awan, Anne Frei

|Mar 31, 2025
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma.

Nirav N Shah, Alfredo S Colina, Bryon D Johnson

Pageof 3

Frequent Collaborators

3 joint publications

Natalie S Callander

3 joint publications

Marcelo C Pasquini

2 joint publications

Nicholas J Hess

2 joint publications

Amy W Hudson